drugset / Trial / NCT02294942
Extended-Release RANCAD in the Patients With Stable Angina Pectoris
RandomizedParallel-groupTriple-blindTreatment
Summary
A double-blind, randomized, placebo-controlled, parallel study to evaluate the effects of add-on RANCAD on exercise tolerance and angina frequency in patients with stable angina pectoris.
Timeline
- Start
- 2014-10
- Primary completion
- 2016-12
- Completion
- 2016-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | RANCAD | Unknown | 500 mg | — |
| Subject | RANCAD | Unknown | 1000 mg | — |
Indications
No indication recorded.